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ABSTRACT
The integrity of the chromatin structure is essen-
tial to every process occurring within eukaryotic nu-
clei. However, there are no reliable tools to decipher
the molecular composition of metaphase chromo-
somes. Here, we have applied infrared nanospec-
troscopy (AFM-IR) to demonstrate molecular differ-
ence between eu- and heterochromatin and generate
infrared maps of single metaphase chromosomes re-
vealing detailed information on their molecular com-
position, with nanometric lateral spatial resolution.
AFM-IR coupled with principal component analysis
has confirmed that chromosome areas containing
euchromatin and heterochromatin are distinguish-
able based on differences in the degree of methyla-
tion. AFM-IR distribution of eu- and heterochromatin
was compared to standard fluorescent staining. We
demonstrate the ability of our methodology to lo-
cate spatially the presence of anticancer drug sites
in metaphase chromosomes and cellular nuclei. We
show that the anticancer `rule breaker` platinum com-
pound [Pt[N(p-HC6F4)CH2]2py2] preferentially binds
to heterochromatin, forming localized discrete foci
due to condensation of DNA interacting with the
drug. Given the importance of DNA methylation in
the development of nearly all types of cancer, there
is potential for infrared nanospectroscopy to be used
to detect gene expression/suppression sites in the
whole genome and to become an early screening tool
for malignancy.
INTRODUCTION
Heterochromatin and euchromatin are two distinct types of
chromatin structure. Heterochromatin is a tightly packed
form of DNA and has a condensed structure, containing
∼20% of the mapped human genome, which can be defined
as transcriptionally inactive, but necessary for the main-
tenance of structural integrity (1–4). Euchromatin is the
lightly packed form of DNA, which is the early replicating
variety of chromatin containing most of the housekeeping
genes (3,4).
One of the main chemical differences between eu- and
heterochromatin is methylation of cytosine. DNA methyla-
tion determines gene expression, maintaining appropriate
cellular functionality and genome integrity. DNA methyla-
tion affects activity of genes but also mechanical properties
of DNA (5–8). These structural modifications may influ-
ence interactions between DNA and proteins (9) or other
molecules such as drugs, dyes and the resistance to strand
separation (10).
The technique of chromosome banding allows for the
identification of individual chromosomes due to unique
banding patterns on the specific regions of a chromosome.
Chromatin organization is usually studied with light mi-
croscopy after the differential digestion of metaphase chro-
mosome regions with chemicals or enzymes followed by
staining with a dye. For example, G-banding, first devel-
oped in 1971 by Seabright (11), is still the most common cy-
togenetic method used to date (12) and consists of treating
chromosomes with trypsin, to digest histones from the eu-
chromatin followed by Giemsa staining. Darkly stained (G-
dark) bands at fixed positions across the chromosomes rep-
resent regions of heterochromatin. The unstained or lightly
stained areas (G-light bands) represent euchromatin. All
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the existing data on the spatial distribution of heterochro-
matin and euchromatin across chromosomes are difficult to
interpret for two main reasons. First, the resolving power
of an optical microscope (∼300 nm) is too low in order to
locate precisely the heterochromatin–euchromatin bound-
aries, especially given the size of a human chromosome,
which is between 2 and 10 m. Second, metaphase chromo-
somes are highly compact thus the location of euchromatin
and heterochromatin observed in the metaphase could dif-
fer from the chromatin locations found in extended inter-
phase (13).
Human chromosome structure was also studied by mi-
croscopy techniques working beyond optical diffraction
limit. Atomic force microscopy (AFM) identified thicker
and thinner areas of chromosomes as dense heterochro-
matin and relaxed euchromatin respectively (14,15). Despite
the nanometric spatial resolution achieved with AFM, the
technique is not capable of delivering chemical and molecu-
lar information, thus the detection of G and R bands relies
solely only on density/height. Label based super-resolution
optical methods promise high resolution and strong sig-
nal intensities (16). Stochastic Optical Reconstruction Mi-
croscopy (STORM) was applied for in situ haplotype vi-
sualization using Oligopaint fluorescence in situ hybridiza-
tion (FISH) probes in order to explore chromatin in sin-
gle cells (17). Additionally, decondensed chromatin struc-
ture at transcription sites (active RNA pol II) was explored
by binding activated localization microscopy with a spa-
tial resolution up to 20 nm (18). Hu et al. employed Light-
sheet Bayesian microscopy for imaging of photoactivable
proteins on heterochromatin in fixed and living human cells
(19), with a lateral resolution 50–60 nm (19). Although,
super resolution optical methods deliver a limited amount
of information on molecular structure. Moreover, fluores-
cence based methodologies require the introduction of la-
bels, which may affect the delicate structure of the chromo-
some. Furthermore, fluorescence based measurements are
also restricted by photobleaching, photoblinking or limited
excited-state lifetimes and the lack of photon flux (20). Vi-
brational spectroscopy has also been applied to study chro-
mosomes. Puppels et al. presented Raman spectra acquired
from single chromosomes (21). This work and many follow-
ing applications of Raman spectroscopy allowed for a label
free investigation of chromosomes structure and composi-
tion (21–24). However, the diffraction limit did not allow for
a detailed investigation into their structure at the nanoscale
(22). Unstained human chromosomes have been analysed
using a combination of backscatter imaging with a dark-
field objective by applying visible and short near-infrared
spectroscopy (25). This methodology enabled the size of the
chromosomes, their refractive index gradients, the position
of the centromers and also exploration more concentrated
heterochromatin areas based on sample density to be deter-
mined (25). The main limitation of this approach is the lack
of information about chemical composition of the chromo-
somes.
In contrast to all methods listed above, a combination
of AFM and Infrared Spectroscopy (IR) allows one to ob-
tain information about physical and chemical properties of
the sample at very high spatial resolution without chemi-
cal labeling (26,27). This can be achieved by the application
of two different techniques, measuring: i) the infrared light
scattered by a scanning probe tip (26,28,29) (Fourier trans-
form infrared nanospectroscopy, nano-FTIR) or ii) the re-
sponse of AFM cantilever sensitivity to sample thermal ex-
pansion caused by an absorption of IR light (27) (phother-
mal induced resonance, AFM-IR). In our work, we used the
second approach, since the photothermal detection has the
strength to be purely related to the imaginary part of the IR
light transmitted to the sample.
A number of biological systems have been investigated
with AFM-IR such as single cells (30–32), bacteria (33,34),
liquid-liquid phase separated protein droplets (35–37) and
amyloid fibrils (26,38–42). The detection of low concentra-
tion chemical substances in cellular nuclei has also been
demonstrated by localization of a rhenium-carbonyl com-
plex after a 1-h incubation with 10 l of an organometal-
lic conjugate (31). Existing knowledge about chromo-
some structure and composition is very broad, but could
be complemented and extended by the application of a
nanoscale label-free analytical method. Here, we apply in-
frared nanospectroscopy (AFM-IR) to explore eu- and het-
erochromatin in single human metaphase chromosomes
to achieve chemical spatial resolution below the diffrac-
tion limit. Using infrared nanospectroscopy, we study the
methylation state at the sub-chromosome scale with a reso-
lution approaching the order of 10 nm, enabling the chemi-
cal characterization of very small amounts of material. Our
article describes the first nano-infrared study of investiga-
tion into metaphase chromosome structure and the first ap-
plication of this technology to image anticancer drug bind-
ing sites to small biological samples such as chromosomes.
Another very important aspect of our studies is direct visu-
alization of DNA methylation, which role and influence on
DNA structure still requires further research (9).
We have applied following systematic approach to gen-
erate eu- and heterochromatin nanoscale maps from sin-
gle chromosomes: i) nanoscale spectra acquisition from
single chromosomes and their comparison with stan-
dard micro and nanoscale spectra of cells, cellular nuclei
and methylated, unmethylated DNA in order to explore
nanospectroscopic markers of DNA methylation in chro-
mosomes, ii) mapping of DNA methylation within chro-
mosomes volume––CH3/OPO distribution, iii) an applica-
tion of statistical analysis in order to fully explore nanoscale
spectral difference between eu- and heterochromatin and
verify/adjust the threshold on CH3/OPO distribution maps
based on spatial location of spectra classified as eu- and
heterochromatin, iv) a comparison of chromosome activ-
ity areas with areas of DNA methylation––a final proof
of nanoscale detection of eu-and heterochromatic sites, v)
an example of our methodology application – mapping of
chemotherapeutic compound distribution in eu- and hete-
rochromatin areas of single chromosome.
MATERIALS AND METHODS
Pt103 compound
Pt103 was synthetized by established method (43) and char-
acterized by IR and F-NMR spectra (44).
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Cell culture
HeLa cells were grown in a humidified incubator at
37◦C in 5% CO2 in complete growth medium composed
of Dulbecco’s Modified Eagle Medium (Life Technolo-
gies) containing 10% of inactivated fetal bovine serum
(FBS) South American (Life Technologies) and 1% of
Penicillin/Streptomycin solution (Life Technologies).
Incubation with the Pt-103
For the drug detection experiment, cells were incubated
with 50 M of [Pt{N(p-HC6F4)CH2}2py2], for 4 h. Before
supplying the culture medium (4 ml per flask) the appro-
priate amount of drug was dissolved in 20 l of acetone.
The same amount of pure acetone was added to the control
samples.
Chromosome preparation
Metaphase chromosomes were obtained from HeLa cells
according to the procedure described in details in Supple-
mentary Data S1.
AFM-IR spectra collection and AFM-IR mapping
Spectra and maps were collected using two commercially
available microscopes nanoIR and nanoIR2 (Anasys, Santa
Barbara, CA, USA), both supplemented with a tunable in-
frared OPO (Optical Parametric Oscillator) lasers (Instru-
mental technical details are described in Supplementary
Data S1). Results were obtained with nanoIR (Figures 1–
7) and nanoIR2 (Figure 5). The first step in the measure-
ment procedure was a generation of a topographical image
of the metaphase chromosomes. Then, based on topogra-
phy, chromosomes were chosen and the absorption of 1240
cm−1, 2952 cm−1 peaks corresponding to mainly phosphate
groups from the DNA backbone and –CH3 groups were
mapped. Pixel size is noted in each figure caption. All spec-
tra were taken in the spectral range of 3600 cm–1 – 1000
cm–1 with 1024 scans co–added. Background of the OPO
laser is presented and discussed in Supplementary Data S2.
Details of data post-processing are described in Supplemen-
tary Data S1.
RESULTS AND DISCUSSION
AFM-IR enables to map simultaneously the morphology
and chemical properties of individual chromosomes at the
nanoscale, by illuminating the sample with IR light at fixed
wavenumber corresponding to a particular chemical bond
vibration (Figure 1). Vertical and lateral resolution of the
instrument are independent and they are defined by dif-
ferent physical constrains. In our work, to define effective
lateral chemical resolution during imaging, we applied two
standard methods. First, we demonstrated the sharpness
of boundaries between eu- and heterochromatic areas in
flat fragment of the chromosome and in small parts of the
chromosome called double minutes (∼60 nm thickness).
Then, we used as model system amyloid fibrillar aggregates,
with nanoscale dimensions, to probe the closest distance at
which two different objects can be still distinguished. Our
measurements indicate that the effective lateral resolution
ranges approximately between 15 − 40 ± 20 nm on chro-
mosomes and double minutes and between 10–30 nm for
amyloid fibrils. This relatively broad range and high value
of the uncertainty are determined by scanning and sampling
rates and are related to several factors affecting the resolu-
tion such as the tip apex size and thermomechanical prop-
erties of the investigated sample (45–50). In addition, our
large error derives from the consideration of divisions maps.
Details are presented in Supplementary Data S3. The verti-
cal resolution is defined by the minimal detectable thermo-
mechanical expansion and it has been demonstrated to be
in the order of 30–50 nm for bottom illumination and few
nanometers for top illumination of the sample by the laser
(38). Furthermore is necessary to consider the depth resolu-
tion of the instrument that is significantly larger than the ef-
fective vertical and lateral spatial resolution. The depth res-
olution is strictly dependent on the indentation depth of the
field inducing thermal expansion of the sample. An evanes-
cent field or infrared wave extends through the sample film
to a distance on the order of the wavelength of light which
is equal to micrometres for the mid infrared spectral range
(27). Therefore the evanescent field (nanoIR) and infrared
beam (nanoIR2) pass through entire thickness of the chro-
mosomes (80–200 nm, Figure 1), which is at least one order
of magnitude smaller than the order of the wavelength of
infrared light (3–10 m).
AFM-IR band assignment of single metaphase chromosome
spectra
The lateral spatial resolution that could be achieved using
SR-FTIR is ∼2.5 m, (wavelength dependent) (51), making
it impossible to record individual spectra of single chromo-
somes. AFM-IR spectra of the chromosome were compared
with spectra of cellular nuclei and DNA collected by con-
ventional FTIR methods to assess whether they are com-
parable with the AFM-IR spectra. Figure 1 shows a com-
parison of: (i) AFM-IR spectra (80 averaged spectra for
each of two slightly different types of spectra collected from
chromosomes, 160 in total) recorded in the regions of three
chromosomes (from three various samples) with each spec-
trum collected using a synchrotron light source: (ii) a spec-
trum of cellular nuclei collected in transmission mode with
the infrared microscope at the Australian Synchrotron, and
a spectrum collected using FTIR spectroscopy: (iii) ATR-
FTIR (Attenuated Total Reflectance––Fourier Transform
Infrared spectroscopy) spectrum of Calf thymus DNA. As
expected, the chromosome spectrum is an equivalent of a
convolution of the cellular nuclei spectrum and the spec-
trum of calf thymus DNA, therefore artifacts related to
optical effects such as scattering were not observed. Each
spectral feature typical for DNA and cellular nuclei are ob-
served in the chromosome spectra including the symmet-
ric and asymmetric stretching bands of phosphate from
the DNA backbone at 1088 cm−1 and 1240 cm−1, respec-
tively (52). Amide I and Amide II bands from histones ap-
pear at 1654 cm−1 and 1549 cm−1, respectively (53–55) and
the symmetric and asymmetric stretching of methyl and
methylene vibrations appear in the spectral range from 3960
cm−1 to 2850 cm−1 (52,53). Detailed band assignments are
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Figure 1. (A) a scheme of chromosome spectra acquisition via AFM-IR (B) A comparison of two kinds of AFM-IR spectra collected from three indepen-
dent chromosomes (80 AFM-IR spectra were averaged for each spectrum kind: blue and red) with SR-FTIR a spectrum of cellular nuclei collected with
the infrared microscope at the Australian Synchrotron (pink) along with a spectrum of ATR-FTIR spectrum of Calf thymus DNA (black).
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listed in Supplementary Table S1 (Supplementary Data S4).
Differences between two described groups of spectra were
observed mainly in bands related to methyl and methy-
lene motions such as sym(CH2), sym(CH3), asym(CH2),
asym(CH3) and in the intensity of the band assigned to
right-handed helices at 1440 cm−1 (52,53). Direct compari-
son of chromosome spectra collected at the nano and micro
scale could not be performed because single chromosomes
are too small to achieve the sufficient signal-to-noise ratio
required when using ATR-FTIR or SR-FTIR spectroscopy.
Furthermore, the sample preparation procedure does not
allow for preparation of bulk samples containing only chro-
mosomes for infrared spectroscopy because chromosomes
are released upon contact with the surface as described in
the methods section and despite Colcemid treatment, only
around 5–15% of cells dependent on the donor’s health, age,
conditions etc. are arrested at metaphase (56,57).
The origin of differences in the methylation degree along sin-
gle metaphase chromosome
To prove further that the technique is able to distinguish be-
tween methylated and unmethylated sites in a DNA in chro-
matin, AFM-IR spectra acquired from metaphase chromo-
somes were compared with the AFM-IR spectra of com-
mercially available methylated and unmethylated DNA.
Figure 2 shows a direct comparison of the average of AFM-
IR spectra typical for lower methylation state (80 spec-
tra) and the chromatin areas with a slightly higher level of
methylation (80 spectra), together with their standard de-
viation. These spectra are compared to AFM-IR spectra
collected from methylated and unmethylated DNA, where
each spectrum is the average of 10 independent measure-
ments. Highly overlapping bands were further resolved by
calculating the second derivatives (Supplementary Data S5
and Figure S6) in the spectral regions of interest including:
(i) methyl and methylene stretching between 3100 cm−1 –
2750 cm−1 (Supplementary Figure S6b) (58–60) and (ii) be-
tween 1520 cm−1 and 1300 cm−1 (Supplementary Figure
S6c) (54,55). In the first type of spectra (red color) an in-
crease in the intensity of the asymmetric stretching vibra-
tion of the methylene and methyl motions at 2927 cm−1
and 2960 cm−1 - 2952 cm−1 is observed. In addition, there
is also an increase in intensity in the methyl deformation
mode from cytosine at 1408 cm−1 (52,53). These spectral
changes were also observed in the spectra of the methylated
DNA but were absent in unmethylated DNA; indicating the
changes come directly from the nucleic acids and not the
surrounding histones. According to previous studies (52)
methylation affects DNA structure, which could be detected
as changes in the infrared spectral range from 1440 cm−1 to
1360 cm−1 (52). The second type of spectra (blue) show an
increase in the intensity of the C = O stretching mode at
1723 cm−1, which is possibly related to the histone acetyla-
tion. This finding is consistent with the literature, which re-
ports that hyperacetylation of the histone tails is typical for
less methylated euchromatin (61). There is also a decrease
in the intensity of the band assigned to the right-handed he-
lices at 1440 cm−1 (52,53) in the spectra collected from more
methylated chromatin. Similar spectral changes were ob-
served in pure methylated DNA compared to unmethylated
DNA, as previously reported by Banyay and Graslund, who
determined specific infrared markers for various degrees of
methylation in d(CCGGCGCCGG)2 (52).
Nanospectroscopic mapping of DNA methylated sites in a
single metaphase chromosome
The next step of an investigation into metaphase chromo-
some structure was mapping of the distribution of methy-
lated sites along a single chromosome. The instrumental
setup enabled us to generate a map for a discrete wavenum-
ber value corresponding to a particular vibration in the
area of interest. The resultant maps show the IR absorption
peak height at a given wavenumber for each pixel. Figure
3 displays the results achieved for a typical human chro-
mosome isolated from HeLa cells including the AFM to-
pography (Figure 3A), the contact resonance frequency of
the AFM cantilever (Figure 3B) showing the distribution
of mechanical properties of the sample, an IR absorption
map at 1240 cm−1 corresponding to the O-P-O asymmetric
stretching mode of dry DNA, being mainly in the A-DNA
form (62,63) (Figure 3C) and an IR absorption map at 2952
cm−1 corresponding to the vibration of the methyl asym-
metric stretching mode (Figure 3D). Methyl and methy-
lene motions are considered as potential markers for dif-
ferent chromatin types because of the density of methylated
purines and pyrimidines, mainly cytosine, which density in-
creases from the euchromatin toward the heterochromatin
(64). Figure 3D shows methyl group distribution, however,
the banding pattern is not visible because this image is af-
fected by the material density/height. To avoid the influence
of chromosome thickness directly related to the amount of
material, the signal collected from the distribution of methyl
groups at 2952 cm−1 (Figure 3D) was divided by the dis-
tribution of phosphate groups at 1240 cm−1 (Figure 3C),
corresponding to the DNA density, which is directly related
to the density/thickness of the chromosomes. The ratio de-
picted in the Figure 3E shows the banding pattern, yellow
areas contain more methylated sites of chromatin and green
areas contain less methylation. In Figure 3E, the pure chem-
ical information from DNA methylation, which is not af-
fected by sample thickness/density within the chromosome,
is clearly shown.
The O-P-O asymmetric stretching vibration from the
DNA backbone at 1240 cm−1 was chosen for normaliza-
tion despite the low IR signal intensity in the spectral range
from 1230 cm−1 – 1190 cm−1, which is related to low laser
power in this spectral range (discussed in Supplementary
Data S2). The normalization to the AFM topography (di-
vision by topography) would not be an appropriate method
because of the heterogeneity of our relatively complex bio-
logical sample (14,27,65).
To observe the banding pattern of chromosomes in-
dependently direct immunofluorescence staining of 5-
methylcytosines (5mC) in DNA was performed using the
Imprint® Monoclonal Anti-5-methylcytosine antibody
produced in mice (Sigma-Aldrich) and counterstained with
propidium iodide (Sigma-Aldrich) for better contrast (Fig-
ure 3F) as described in detail in Supplementary Data S6
(66,67). Based on the precise calculations of ratios of chro-
mosome p and q arms, all chromosomes from a particu-
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Figure 2. A comparison of AFM-IR infrared spectra collected from chromosomes, methylated DNA and unmethylated DNA, 80 averaged spectra collected
from chromosome areas containing highly methylated chromatin, 80 averaged spectra collected from chromosome areas areas containing lowly methylated
chromatin, 10 averaged spectra collected from methylated DNA and 10 averaged spectra collected from unmethylated DNA.
Figure 3. The AFM-IR results achieved for the typical human chromosome isolated from HeLa cell: (A) AFM topography, (B) the contact resonance
frequency of AFM cantilever correlated to the local stiffness to demonstrate that the banding contrast is related with chemical structure not local stiffness
heterogeneity, (C) the integrated area of an absorption band at 1240 cm−1 corresponding to the O-P-O asymmetric stretching vibration, (D) the integrated
area of an absorption band at 2952 cm−1 corresponding to the vibration of methyl (-CH3) asymmetric stretching vibration, (E) the ratio of the integrated
absorption band at 2952 cm−1 to the absorption band at 1240 cm−1, (F) anty 5-methylcytosine direct immunostaining counterstained with propidium
iodide, similarities between (E) and (F) can be observed: high intensity of signal from 5- methylcytosine (F) correspond to high CH3/OPO ratio (E,
yellow), (G) a direct comparison of profiles extracted along red (AFM-IR) and blue (fluorescence) lines; chromosome thickness: 190 – 210 nm, pixel size
7.8 × 7.8 nm.
lar metaphase were classified and ordered in a karyogram
(Supplementary Data S6 and Figure S7). The ratio is typi-
cal for each individual chromosome. Therefore, it was pos-
sible to recognize the chromosome mapped by AFM-IR as
chromosome 2 based on a comparison with another chro-
mosome 2 analyzed by immunofluorescence. As expected,
a similar distribution in the methylation-banding pattern
was observed in both chromosomes as shown in Figure 3E
and F. The high intensity of signal from 5-methylcytosine
(Figure 3F) corresponds to high CH3/OPO ratio (Figure
3E, yellow). For a more quantitative comparison of spectro-
scopic and fluorescence data we are presenting profiles ex-
tracted from AFM-IR and fluorescence images along lines
marked on both maps. Highly methylated areas are high-
lighted in yellow. This direct comparison proved that highly
methylated areas could be better resolved with AFM-IR
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/47/18/e108/5538718 by U
niw
ersytet Jagiellonski user on 07 N
ovem
ber 2019
PAGE 7 OF 15 Nucleic Acids Research, 2019, Vol. 47, No. 18 e108
compared to fluorescence microscopy. It is known, that the
proportion of active and inactive chromatin is likely to be
preserved in metaphase chromosomes (68). However, line
profiles extracted along the two chromosomes do not ideally
coincide with each other. The observed inhomogeneity is re-
lated to the fact that both chromosomes have been extracted
from different cells, which are likely to be in slightly differ-
ent stages of metaphase. Even if both chromosomes are in
metaphase, the chromatin condensation and the size (length
and thickness) of chromosomes, which determines the loca-
tion of eu- and heterochromatic areas, is likely to be slightly
different (69,70). Additionally, these two cells could have
slightly different metabolic activity and indeed different eu-
/heterochromatin content (66,67,71). Upon the deposition
on the substrate the chromosome arms may also bend and
therefore the eu- and heterochromatin areas observed in the
profiles could be shifted relative to one another. Moreover,
fluorescence microscopy is limited because DNA bases in-
cluding 5mC modified bases are hidden within the double-
stranded DNA helix (72). AFM-IR spectroscopy can detect
the degree of methylation from the 3D volume of the sample
under the AFM tip (73) as schematically presented in Fig-
ure 1. Therefore, AFM-IR provides information from the
area of the chromosome, which could be unavailable using
fluorescence probes. These factors cause the inhomogeneity
observed between results obtained with AFM-IR and fluo-
rescence microscopy.
Principal component analysis (PCA) analysis was applied
to reduce the dimensionality of the data set and to resolve
hidden spectral differences between eu- and heterochro-
matin. The main results of PCA are the scores plots and
loadings plots. Original variables––spectra are projected in
the space of new variables called principal components PCs,
which are based on linear combinations of the original vari-
ables. Scores plots project each spectrum as a single point on
a new coordinate system, defined by principal components.
Each PC explains a percentage of the total variance within
the data set (PC1>PC-2>. . .>PCn). Therefore, only several
first PCs are taken into consideration. Loadings plots show
which bands are varying the most and are responsible for
the clustering observable in the scores plots. In our studies
several PCA models described in the next paragraphs were
tested.
For the first model of PCA the spectra acquired from the
single metaphase chromosome presented in Figure 4A–C,
were chosen, because areas containing heterochromatin are
very small and the banding pattern is not that easily visual-
ized in the infrared maps (Figure 4C). However, it was possi-
ble to select the color threshold in order to visualise the eu-
and heterochromatin areas. In order to verify further that
the spectral differences observed between the two chromo-
some areas containing mainly heterochromatin or euchro-
matin are related to methylated and unmethylated deoxyri-
bonucleic acid PCA was performed on AFM-IR spectra
collected from methylated and unmethylated DNA. In total
four PCA models were calculated for spectra acquired from
both DNA and chromosomes: (i) in the finger print region:
1750 cm−1––1230 cm−1 and (ii) in the methyl and methylene
stretching region 3070 cm−1–2755 cm−1. The most defini-
tive separation was related to the level of methylation as
shown in the methyl and methylene stretching spectral re-
gion 3070 cm−1–2755 cm−1. The data is presented in Figure
4 and the results of the PCA in fingerprint spectral range
1750 cm−1–1230 cm−1 are shown and discussed in Supple-
mentary Data S7 and 8.
Figure 4D demonstrates a separation of spectra into two
groups collected from areas containing (i) heterochromatin
(marked by red arrows on Figure 4C) and (ii) euchromatin
(marked by blue arrows on Figure 4C). The separation
along PC-1, explains 47% of the total variance within the
dataset. Spectra collected from euchromatin are clustered in
positive PC-1 space and all positive bands presented on the
loading plot (Figure 4E) of PC-1 are typical for these spec-
tra. Spectra collected from the heterochromatin are clus-
tered in negative PC-1 space, which suggests that all neg-
ative bands in the PC-1 loadings plot are characteristic for
heterochromatin. The loadings plot demonstrates that PC-
1 is positively correlated with the CH3 asymmetric stretch-
ing vibration of the methyl group at 2960 cm−1 (spectra in
positive PC-1 space - euchromatin) and it is negatively cor-
related with the same group at 2952 cm−1 (spectra in neg-
ative PC-1 space––heterochromatin). The results indicate a
different position of the CH3 motion in the AFM-IR spec-
tra collected from these two groups of spectra, and sug-
gest that one of these two varieties of chromatin has CH3
groups in slightly different chemical environments. The PC-
2 loadings plot (Figure 4C, red line) explains the separation
along PC-2 (35% of total variance). This loading is domi-
nated by CH3 symmetric and asymmetric stretching at 2905
cm−1 and 2960 cm−1, respectively. The symmetric stretching
of the CH2 group at 2854 cm−1 is also an important load-
ing that discerns the two groupings along PC-2. A separa-
tion along PC-3, which accounts for 12% of total variance,
is dominated by a band assigned to the CH3 asymmetric
stretching vibration at 2950 cm−1.
Second model of PCA was performed on AFM-IR point
spectra of DNA (Figure 4F and G) in the methyl and methy-
lene stretching region. This PCA model confirmed that the
degree of DNA methylation can be detected by infrared
absorption. Characteristic features responsible for cluster-
ing of methylated and unmethylated DNA spectra (Fig-
ure 4G) are very similar to spectral features responsible for
the clustering of spectra collected from hetero- and euchro-
matin (Figure 4E). PC-1 is positively correlated with the
CH3 asymmetric stretching vibration at 2950 cm−1 (methy-
lated DNA) and negatively with the same band at 2962
cm−1 (unmethylated DNA). This result indicates a different
chemical environment/position of the CH3 group in methy-
lated DNA compared with unmethylated DNA. Separation
along PC-2 (unmethylated positive, methylated negative) is
dominated by asymmetric stretching of CH3 at 2950 cm−1
(methylated DNA) and symmetric stretching of CH3 at
2890 cm−1 (unmethylated DNA). PC-3 is dominated by the
asymmetric stretching vibration of CH3 at 2960 cm−1 and
the symmetric stretching vibration of CH3 at 2880 cm−1.
In order to distinguish eu- from heterochromatin it is
sufficient to use only the first PC (separation along PC-
1). However, to explore fully spectral differences within the
data set three PCs: PC-1, PC-2 and PC-3 should be taken
into consideration. The application of PCA was indispens-
able to verify that the CH3/OPO ratio maps reflected the
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Figure 4. The results of PCA performed on spectra collected from a single chromosome and DNA in the spectral range from 3070 cm−1 to 2755 cm−1. (A)
AFM topography of chromosomes isolated from HeLa cells, chromosome thickness 70–90 nm. (B) AFM topography of one chromosome isolated from
HeLa cells. (C) The ratio of the absorption for the 2952 cm−1/1240 cm−1 bands with areas of the spectral collection marked by red arrows (heterochromatin)
and blue arrows (euchromatin) where the spectra were recorded pixel size 6.4 × 6.4 nm. (D) Scores plot of spectra collected from a single chromosome
presented in (C) showing scores projected onto PC-1, PC-2, PC-3. (E) Loadings plot corresponding showing loadings explaining the separation along PC-1,
PC-2 and PC-3 presented in (D). (F) Scores plot of DNA spectra showing scores projected onto PC-1, PC-2, PC-3. (G) Loadings plot showing loadings
explaining the separation along PC-1, PC-2 and PC-3 presented in (F).
real distribution of hetero- and euchromatin along the chro-
mosome. The location of each single spectrum classified
by PCA as eu- or heterochromatin was carefully correlated
with the CH3/OPO ratio map. Therefore, we can unequiv-
ocally verify the eu-/heterochromatin areas by: (i) mapping
the density of low/high methylene distribution and (ii) sta-
tistical confirmation that the collected spectra were indeed
classified correctly as eu-/heterochromatin. The threshold
of OPO/CH3 maps was different for each chromosome
(Figures 3–5 and Supplementary Figure S11) and selected
carefully in order to demonstrate the banding patterns and
completed by PCA results, details can be found in Supple-
mentary Data S1.
A comparison of metaphase chromosome methylation level
and chromatin activity
The chromatin activity can be directly observed by compar-
ing of the distribution of methylated DNA in both Xs of ac-
tive and inactive female chromosomes (Figure 5). In order
to prove the ability of AFM-IR to follow active (unmethy-
lated DNA) and inactive (methylated DNA) chromatin,
two single metaphase X female chromosomes: one inactive
(fully methylated DNA) and the second one, active (con-
taining eu- and heterochromatin areas, forming a charac-
teristic banding pattern) were investigated. Both metaphase
X female chromosomes analysed were extracted from the
same metaphase cell. A distribution map of methylation
(CH3/O-P-O ratio) in the two X chromosomes is shown
in Figure 5b,e. The results have been compiled based on
the distribution of DNA methylation characterized by 5-
methylcytosines (Figure 5C and F).
Additionally, to confirm the quality of the obtained re-
sults, and the more detailed information delivered with re-
spect to previously described methods FISH was applied us-
ing an Alu probe, which is described in detail in the Supple-
mentary Data S9 (74,75). The total amounts of chromatin,
heterochromatin and euchromatin were precisely calculated
in each single chromosome of the entire human genome
using DNA sequencing (76,77). The results provided by
The Human Genome Sequencing Consortium are consis-
tent with the amounts of the particular type of chromatin,
which was detected by infrared nanospectroscopy. By in-
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Figure 5. AFM-IR on Xs female chromosomes: (A and D) AFM topogra-
phy of active X (A) and inactive––methylated X (D) female chromosome.
(B and E) The ratio of the integrated absorption band at 2952 cm−1 to
the absorption band at 1240 cm−1 of active X (B) and inactive X (E) fe-
male chromosome. (C and F) anty 5-methylcytosine direct immunostain-
ing counterstained with propidium iodide of active X (C) and inactive X
(F) female chromosome, similarities between B, C and E, F can be ob-
served; chromosome thickness Xa 65 – 80 nm, Xi 60 – 80 nm, pixel sizes
Xa 7.5 × 14 nm, Xi 6.2 × 14 nm.
tegrating all of the color pixels attributed to heterochro-
matin, we have calculated the percentage of eu- and het-
erochromatin in each mapped chromosome and we com-
pared with corresponding values in the literature data, see
detailed calculations in Supplementary Data S10. The to-
tal amount of heterochromatin varies from 2.13 to 52.15%
for chromosome 2 and Xi (inactive X chromosome), re-
spectively. The results for chromosome 2 and other chro-
mosomes (Supplementary Data S10) are slightly above the
values presented in the literature (76,77). The ratio be-
tween the two states of chromatin in each cell depends on
many criteria including: type and stage of the cell (growth
phase), inter-individual variations between donors, prob-
ability of unknown disease etc. Therefore, differences be-
tween the amount of heterochromatin obtained from AFM-
IR maps and the literature data (77,78) (averaged data pro-
vided by International Human Genome Sequencing Con-
sortium) are slightly different. The inactive X chromosome
was not sequenced because it does not contain active DNA
(76,77,79). Literature is lacking information on the percent-
age of methylated DNA in inactive X chromosomes and
therefore the result obtained using AFM-IR cannot be com-
pared to any other technique. The slight excess is probably
related to the high sensitivity of AFM-IR to histone methy-
lation. A good agreement between AFM-IR and literature
data has confirmed the appropriate selection of color (inten-
sity) threshold when calculating the AFM-IR maps using
the (CH3/OPO) ratio. The threshold adjustment is strictly
related with statistical analysis and discussed in next para-
graph.
Direct comparison of the active and inactive X chromo-
somes constitutes the most important outcome of this re-
search, which is definitive proof that infrared nanospec-
troscopy mapping of inactive heterochromatin and active
euchromatin areas in metaphase chromosomes is indeed
possible. All of the results presented above confirmed that
we were able to map the high and low methylated areas of
the chromosome. Here we have proven that AFM-IR map-
ping supported with appropriate data analysis is able to dif-
ferentiate between active and inactive X chromosomes de-
rived from the same metaphase cell.
Mapping of platinum anticancer drug distribution in a single
metaphase chromosome
Vibrational spectroscopy can play a significant role in stud-
ies of the interaction between chemotherapeutic drugs such
as metallo-drugs and single cells. This approach enables the
monitoring of the biochemical impact and physiological re-
action of cells to anticancer agents (80,81). Here, we show
that AFM-IR spectroscopy coupled with PCA can identify
which type of chromatin is more sensitive to the binding of
a Pt anticancer drug.
The methodology is exemplified by the ‘rule breaker’ plat-
inum anticancer drug, [Pt{N(p-HC6F4)CH2}2py2] Pt-103,
which is a four coordinate platinum(II) complex. This com-
pound does not have hydrogen substituents on the donor ni-
trogen atoms (81). The drug already has shown anticancer
activity against cisplatin-resistant cell lines and is active in
vivo (81,82). Pt-103 has caused nearly complete tumor re-
gression in the ADJ/PC6 mouse tumor model (83). This
very high cytotoxicity, and enhanced cellular uptake in cis-
platin resistant cells (83) is related to greater hydropho-
bicity of Pt103 in comparison to cisplatin (81,84). Un-
der physiological conditions (pH ∼7.8) prior to interac-
tion with DNA Pt-103 loses pyridine rings or more likely
{N(p-HC6F4)CH2}2- upon nucleophilic attack. In our re-
cent studies, we applied X-ray emission spectroscopy and
multiscale molecular dynamics calculation in order to test
those two possible pathways of hydrolysis in the drug dis-
solved in aqueous buffer solution. X-ray studies confirmed
that more likely the {N(p-HC6F4)CH2}2- moiety acts as the
leaving group and then [Pt(Py2)]2+ ligand interacts with ade-
nine rather than guanine (85). However the dissociation of
pyridine is also possible (85).
Here, the accumulation and location of the drug (discrete
foci) was detected by AFM-IR and the type of chromatin in
these areas was explored by applying PCA to spectra col-
lected from the areas neighbouring the binding places of
drug. Considering the lateral spatial resolution calculated
in Supplementary Data S3 the location of the drug foci can
be determined with nanometric precision (15–40 nm) in the
plane of the sample. The location of the drug foci in z direc-
tion can not be determined because the signal was acquired
from entire thickness of the chromosome (Figure 1).
HeLa cells were incubated with 50 M of Pt- 103 for
4 h prior to chromosome isolation. AFM topographies of
single investigated chromosomes isolated from control cells
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and cells treated with Pt-103 are shown in Figure 6A and
B, respectively. The AFM-topographical images showed no
differences between control and chromosomes treated with
the anticancer drug. Furthermore, an IR absorption map
of the band assigned to the asymmetric phosphodiester
stretching vibration at 1240 cm−1 does not indicate any dif-
ferences between them (Figure 6C and D). However, in the
chromosomes isolated from the cells treated with the drug,
there were small areas with a strong absorption band at
2916 cm−1 (H-C-H asymmetric stretching motions) in com-
parison with untreated chromosomes (Figure 6E and F). A
strong band related to H-C-H asymmetric stretching vibra-
tions was also observed at 2898 cm−1 (86) in the pure drug
spectrum (Figure 6g). One can compare profiles extracted
along the lines marked in the AFM-IR maps showing the
distribution of the 1240 cm−1 and 2916 cm−1 bands (Figure
6E and F). In each of the 20 investigated chromosomes iso-
lated from the cells incubated with the drug, this very strong
absorption at 2916 cm−1 was observed in multiple instances.
Drug foci were observed in 65–75% of the metaphase chro-
mosomes. For each chromosome 1–4 foci were detected.
The experiment was repeated in triplicate.
Reproducible spectra were collected from the places in-
dicating very strong absorption at 2916 cm−1. In Figure
6G one of the AFM-IR spectra (blue spectrum) is pre-
sented and compared with a spectrum collected very close
to the region of the drug binding (green spectrum) in the
same type of chromatin. The regions within the chromo-
some marked by arrows are where the spectra were recorded
(Figure 6F). The AFM-IR spectrum of pure Pt-103 is also
presented in Figure 6G for comparison. To assign the vi-
brational modes in the spectrum of the Pt-103 and the
spectrum collected from the chromosome treated with the
drug, we calculated the theoretical IR spectra of the pure
Pt-103 molecule. Calculations (Supplementary Data S11)
were done in the liquid phase. The CH2 asymmetric and
symmetric stretching vibrations are observed in the AFM-
IR spectrum of the pure drug at 2898 cm−1 and 2840
cm−1, respectively, and in the spectrum of the drug already
bonded to the DNA at 2916 cm−1 and 2844 cm−1. The pres-
ence of these peaks confirms that with the AFM-IR spec-
troscopy we have detected Pt-103 molecules inside the chro-
mosomes. The drug influence was also detected in the fin-
gerprint spectral region. The most significant marker of the
Pt-103 molecule was an intense peak at 1628 cm−1 from
the tetrafluorophenyl ring breathing mode (aromatic C = C
stretching) in the pure drug. A relatively low intensity band
from the tetrafluorophenyl ring breathing was detected at
1610 cm−1 in the spectra from chromosomes isolated from
the cell treated with Pt-103. Summarizing, our experimen-
tal data supported by theoretical calculations confirms the
existence of the tetrafluorophenyl ring and the (-CH2-CH2-
) group within the chromosome volume as a signature of
the Pt-103 compound. Our previous X-ray scattering stud-
ies (85) unveiled a hydrolysis process of Pt-103 and binding
nature to DNA (preferentially adenine).
Visualization of the subcellular distribution of anticancer
compounds yields unique, valuable information on the lo-
cation of the sites relevant to their biological activity. In-
frared nanospectroscopy was applied also to demonstrate
the drug distribution in isolated cellular nuclei, with nano-
metric spatial resolution. HeLa cells were incubated with 50
M of Pt-103 for 4 h and then cellular nuclei were isolated
according to the procedure described previously by Lipiec
et al. (87). Detailed results are presented in Supplementary
Data S12. Obtained data indicated an accumulation of Pt-
103 discrete foci in the chromatin volume. Observations of
anticancer drugs’ distribution in cells/celluar nuclei are rare
because such studies require an application of nanoscale
analytical techniques. With infrared nanospectroscopy we
have detected discrete foci of the platinum drug in single
chromosomes (Figure 6) and isolated cellular nuclei (Sup-
plementary Figure S14)
Transmission Electron Microscopy/nano Secondary
Ions Mass Spectrometry (TEM/NanoSIMS) studies have
confirmed an accumulation of concentrated Pt hotspots in
nuclei of A2780 cells treated with cisplatin (88). Discrete
foci in cellular nuclei have also been observed in other
studies of cisplatin distribution in cancer cells (88–90).
Discrete accumulation of platinum anticancer drugs
(cisplatin and [{cis-Pt(NH3)2}2(-OH)(-tetrazolato-
N2,N3)]2+ (5-H-Y) ) was observed also with scanning
X-ray fluorescence microscopy (SXFM) (91). While TEM,
nanoSIMS and SXFM correlated the distribution of Pt
with phosphorus-rich chromatin regions, confirmed the
binding affinity of the Pt-compounds DNA, and allowed
for observation of Pt hotspots observation in cellular
nuclei but they did not explain explicitly localised binding
of Pt-drugs to DNA. Hou et al. based on AFM studies
proposed a model, which explain DNA condensation
caused by cisplatin (92). According to AFM observations
cisplatin/oxaliplatin di-adducts induce local distortions
of DNA and then through formation of distant crosslinks
micro-loops of ∼20 nm appear. In the next step further
crosslinks, lead to large aggregates and then a compact
globule. Hou et al. postulated that this mechanism explains
also the effect of other platinum anti-cancer drugs that
are analogous to cisplatin (92) such as Pt-103. Our studies
involved also an investigation into interaction between
DNA pUC 19 plasmid with 200 mM of Pt-103 in order to
confirm that the drug condenses DNA, leading to compact
globule formation. Globular features were observed in
AFM topographies of DNA incubated with Pt-103 for 2
and 12 h as presented in Supplementary Figure S15.
To determine the type of chromatin that preferentially
binds to the Pt compound AFM-IR spectra were collected
very close (at a distance <200 nm) to the places in which
the drug was bonded. Around 100 spectra were collected
from eight various chromosomes and modeled using PCA
to assist in discriminating eu- from heterochromatin. The
PCA model was constructed by combining the euchromatin
and heterochromatin spectra used for generating the model
in Figure 4 with the 50 spectra mentioned above (Figure
7). The first Principal component explains 87% of the to-
tal variance and is related to the differences between single
chromosomes. Such differences include the size/thickness
and density of the chromosome, which depends on the chro-
mosomal stage (early/late metaphase) (3,4,11–13). How-
ever, the loadings plot shows that PC-2 (explaining 7% of
total variance) and PC-3 (2%) are related to the spectral
differences between eu- and heterochromatin. The model
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Figure 6. The detection of the Pt compound Pt103 interacting with the heterochromatin in single chromosome. (A) AFM topography of one chromosome
isolated from control HeLa cell chromosome thickness 50–60 nm, pixel size 8 × 8 nm. (B) AFM topography of chromosomes isolated from HeLa cell
treated with the platinum drug with the extracted height profile, chromosome thickness 55–70 nm, pixel size 10 × 10 nm. (C) The distribution of an
absorption for the 1240 cm−1 band in control chromosome. (D) The distribution of an absorption for the 1240 cm−1 band in Pt-103 treated chromosome.
(E) The absorption for the 2916 cm−1 band in control chromosome. (F) The absorption for the 2916 cm−1 band in Pt-103 treated chromosome with the
extracted height profile. (G) Typical AFM-IR spectra collected from pure Pt compound and places marked in (F).
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Figure 7. Classification spectra collected from chromatin interacting with the Pt-103, PCA analysis: (A) scores plot showing the clustering of spectra
collected from eu- (blue) and heterochromatin (red) areas of single chromosome and spectra collected from chromatin interacting with the drug in eight
various chromosomes (green) in the spectral range from 3070 cm−1 to 2755 cm−1, (B) loadings plot for A.
shows spectra collected from chromatin interacting with the
drug clustering with the spectra of heterochromatin. PC-2
is negatively correlated to the CH3 band at 2952 cm−1 (het-
erochromatin) and positively correlated to a band at 2960
cm−1 (euchromatin) indicating two different chemical en-
vironments for the CH3 groups. This shift is significant in
separating eu- and heterochromatin along PC2 in the PC1
versus PC2 scores plot. Similar loadings were observed in
the previous PCA model applied to spectra collected from
just one chromosome that distinguished euchromatin from
heterochomatin (Figure 4D and E). The results indicate that
Pt103 preferentially binds to heterochromatin and demon-
strates the potential of AFM-IR to detect drug-binding sites
in chromosomes. Heterochromatic regions tend to be rich
with adenine and thymine pairs, therefore a detection of
the Pt-103 mainly in heterochromatin areas confirmed the
result of X-ray scattering studies (85), that adenine is the
main target of this Pt compound attack. In contrast, cis-
platin binds preferentially to guanine (93) and can be found
rather in euchromatin areas (61), which are rich with cyto-
sine and guanine pairs.
CONCLUSION
In summary, the main scientific achievement of the work
is the successful application of AFM-IR to detect DNA
methylation status in single human metaphase chromo-
somes at a spatial resolution in the order of the AFM tip ra-
dius. This novel application of AFM-IR coupled with mul-
tivariate data analysis makes it possible to distinguish areas
containing eu- and heterochromatin based on pure chemi-
cal information/the presence of the methyl motions, with-
out any chemical labeling. Additionally, we have verified the
ability of particular chromatin type to bind the anti-cancer
drug Pt-103. This anti-cancer agent was found to bind pref-
erentially to heterochromatin proving the versatility of our
methodology and its usefulness to investigate the mecha-
nism of action of chemotherapeutic compounds. The devel-
oped methodology can be used to routinely map eu- and
heterochromatic areas in chromosomes and for the deep in-
vestigation into the interaction between a particular type of
chromatin and chemotherapeutic drugs. The experimental
approach presented here is an efficient tool for nucleic acid,
genetic and also pharmaceutical research.
However, in order to explore fully chromatin structure
and composition of a single metaphase chromosome, a sys-
tematic approach is required. This approach involves sev-
eral important steps: AFM-IR mapping of methylene and
phosphate motions, collection of at least 100 single spec-
tra along a single chromosome, PCA analysis, and appro-
priate threshold choice in CH3/OPO map basing on PCA
statistical classification of single spectra. Only following all
these fundamental steps, this tool could be applied to detect
sites of increased methylation and interaction of chemother-
apeutic drugs in chromosomes. The extremely high spa-
tial resolution of AFM-IR enables molecular imaging of
a single metaphase chromosome, thereby opening up new
possibilities for detecting chromosome abnormalities and
drug interactions. At last, the development of AFM-IR
working in a native liquid environment with vertical reso-
lution of a few hundreds of nanometers has been recently
demonstrated (41). The future development of resolution of
AFM-IR in liquid promises new possibilities for detecting
chromosome abnormalities and drug interactions simulta-
neously with conventional fluorescent methods.
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